Publications by authors named "Jule Ussmann"

Claim this Profile
T
The sequence of 12 Gy total body irradiation and cyclophosphamide does not impact outcomes in AML patients receiving myeloablative allogeneic stem cell transplantation.
Georg-Nikolaus Franke, Jule Ussmann, Donata Backhaus, Nils Henrik Nicolay, Thomas Kuhnt

Bone Marrow Transplant· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic stem cell transplantation for MDS-clinical issues, choosing preparative regimens and outcome.
Lara Bischof, Jule Ussmann, Uwe Platzbecker, Madlen Jentzsch, Georg-Nikolaus Franke

Leuk Lymphoma· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Evolving WHO and ICC Classifications on Prognosis and Outcomes in AML Patients Undergoing Allogeneic Stem Cell Transplantation.
Jacob Jendro, Jule Ussmann, Dominic Brauer, Donata Backhaus, Lara Bischof

Am J Hematol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-associated differences in outcome of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation.
Jule Ussmann, Lara Bischof, Donata Backhaus, Dominic Brauer, Jacob Jendro

Blood Cancer J· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of PET/CT for CAR T cell therapy in relapsed/refractory multiple myeloma.
Patrick Born, David Fandrei, Song Yau Wang, Carmen Perez-Fernandez, Luise Fischer, Jule Ussmann

Hemasphere· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell multiomic dissection of response and resistance to chimeric antigen receptor T cells against BCMA in relapsed multiple myeloma.
Michael Rade, Nora Grieb, Ronald Weiss, Jaren Sia, Luise Fischer, Jule Ussmann

Nat Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantifying MRD in AML patients prior to allogeneic stem cell transplantation: Where to draw the line?
Sebastian Schwind, Lara Bischof, Marius Bill, Juliane Grimm, Jule Ussmann

Hemasphere· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma.
Luise Fischer, Nora Grieb, Patrick Born, Ronald Weiss, Sabine Seiffert, Jule Ussmann

Leukemia· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of measurable residual clonal hematopoiesis in acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation.
Lara Bischof, Jule Ussmann, Juliane Grimm, Marius Bill, Dominic Brauer

Leukemia· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Implications of the -ITD Allelic Ratio in Acute Myeloid Leukemia in the Context of an Allogeneic Stem Cell Transplantation.
Madlen Jentzsch, Lara Bischof, Dominic Brauer, Donata Backhaus, Jule Ussmann

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation.
Madlen Jentzsch, Lara Bischof, Jule Ussmann, Donata Backhaus, Dominic Brauer

Blood Cancer J· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis